Power Lunch Morning Brief

A jogger runs past the United States Capitol building at sunrise in Washington, D.C.
Pete Marovich | Bloomberg | Getty Images
A jogger runs past the United States Capitol building at sunrise in Washington, D.C.

A daily morning look at the financial stories you need to know to start the day


-BREAKING: US stock futures are much higher right now as the markets like what they've just heard from the European Central Bank.


-Crude prices are flat after closing yesterday at 2016 highs.

-Gasoline prices jumped 2 cents overnight to$1.84/gallon, national average.

-Iran is trying to lure foreign oil investors.


-Last night's Democratic presidential debate focused on immigration and both candidates made their pitches to Latino voters.

-Just about every poll shows Donald Trump with a big lead in winner-take-all Florida.

-An anti-trade sentiment is growing among the voters in both parties. That's something AFL-CIO chief Richard Trumka seizes on in an op-ed he writes today in the USA Today. But the funny thing is, while he mimics a lot of Donald Trump's rhetoric and uses his examples, Trumka never once mentions Trump's name in the piece! Now that's politics!

-A survey of corporate CFOs shows that a majority now believe Donald Trump will be the GOP nominee.

-Twitter is taking severe heat for shutting down a grassroots anti-Hillary hashtag, (#WhichHillary), and appearing to be fully in Mrs. Clinton's corner.


-Thanks to the info given to us by an English-speaking ISIS captive, the US was able to find and bomb ISIS chemical weapons facilities yesterday.

-North Korea fueled growing tensions in the region today by shooting ballistic missiles into the sea.

-The Pentagon is defending its use of spy drones over the US.

-As Sen. John McCain steps up his criticism of the new B-21 Bomber program, the Pentagon is warning Congress that the government will have to pay Northrop Grumman $300 million in breakup fees if the program is scrapped.

-The market for military radar is expected to reach the $13 billion mark in four years.


-The first attempted uterus transplant has failed.

-Expect a big reaction to a new Washington Post story today about the Novartis leukemia drug Gleevec. The drug's price has soared since it was introduced in 2001, despite lots of cheaper competing drugs coming to the market.


-The White House is interviewing five potential Supreme Court nominees.